Trulieve's NYSE Debut Shows How Rescheduling Reshapes MSO Economics
Trulieve Cannabis Corporation used its second-quarter 2026 earnings call to mark a genuine structural turning point for the multi-state operator: a listing on the New York Stock Exchange, the removal
